SEC Form 5 · accession 0001126234-19-000016
NEWLINK GENETICS CORP · (NLNK)
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eugene P. Kennedy
Officer — Chief Medical Officer
Period of report
Dec 31, 2018
Accepted (ET)
Feb 14, 2019 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001126234
Table I — non-derivative securities
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,105 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in one installment on January 4, 2020, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
- F2Includes 940 shares acquired under the NewLink Genetics Corporation 2010 Employee Stock Purchase Plan on June 30, 2018.